MX2019000812A - Formulacion para analogos anticolinergicos blandos. - Google Patents

Formulacion para analogos anticolinergicos blandos.

Info

Publication number
MX2019000812A
MX2019000812A MX2019000812A MX2019000812A MX2019000812A MX 2019000812 A MX2019000812 A MX 2019000812A MX 2019000812 A MX2019000812 A MX 2019000812A MX 2019000812 A MX2019000812 A MX 2019000812A MX 2019000812 A MX2019000812 A MX 2019000812A
Authority
MX
Mexico
Prior art keywords
formulation
soft
soft anticholinergic
hyperhidrosis
anticholinergic analogs
Prior art date
Application number
MX2019000812A
Other languages
English (en)
Inventor
S Bodor Nicholas
Angulo David
J Koleng John
Original Assignee
Bodor Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bodor Laboratories Inc filed Critical Bodor Laboratories Inc
Publication of MX2019000812A publication Critical patent/MX2019000812A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Las formulaciones tópicas que comprenden glicopirrolatos blandos son útiles para tratar afecciones de sudoración excesiva en sujetos, tales como humanos que sufren de hiperhidrosis. Preferiblemente, se proporciona al menos un agente anticolinérgico en una cantidad o concentración efectiva en una formulación anhidra que puede inhibir la transpiración excesiva que resulta de una afección tal como hiperhidrosis.
MX2019000812A 2016-07-21 2017-07-20 Formulacion para analogos anticolinergicos blandos. MX2019000812A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662365037P 2016-07-21 2016-07-21
PCT/US2017/043106 WO2018017852A1 (en) 2016-07-21 2017-07-20 Formulation for soft anticholinergic analogs

Publications (1)

Publication Number Publication Date
MX2019000812A true MX2019000812A (es) 2019-06-20

Family

ID=60989819

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2019000812A MX2019000812A (es) 2016-07-21 2017-07-20 Formulacion para analogos anticolinergicos blandos.
MX2022009375A MX2022009375A (es) 2016-07-21 2019-01-18 Formulacion para analogos anticolinergicos blandos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2022009375A MX2022009375A (es) 2016-07-21 2019-01-18 Formulacion para analogos anticolinergicos blandos.

Country Status (17)

Country Link
US (5) US11123325B2 (es)
EP (2) EP4218725A1 (es)
AU (2) AU2017298469B2 (es)
BR (1) BR112019001081B1 (es)
CA (1) CA3031361C (es)
DK (1) DK3487475T3 (es)
ES (1) ES2954308T3 (es)
FI (1) FI3487475T3 (es)
HU (1) HUE062905T2 (es)
IL (2) IL264311B (es)
MX (2) MX2019000812A (es)
PH (1) PH12019500142A1 (es)
PL (1) PL3487475T3 (es)
PT (1) PT3487475T (es)
TW (2) TWI719046B (es)
WO (1) WO2018017852A1 (es)
ZA (1) ZA201901060B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6513667B2 (ja) 2013-08-08 2019-05-15 ノヴァン，インコーポレイテッド 局所用組成物およびそれを使用する方法
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
TWI719046B (zh) * 2016-07-21 2021-02-21 美商波德實驗股份有限公司 軟性抗膽鹼類似物之製劑
WO2020020879A1 (en) * 2018-07-24 2020-01-30 Dr. August Wolff Gmbh & Co. Kg Arzneimittel Topical emulsion of an anticholinergic compound
WO2021177256A1 (ja) 2020-03-03 2021-09-10 科研製薬株式会社 ソフピロニウム臭化物を含有する医薬
WO2021177257A1 (ja) 2020-03-03 2021-09-10 科研製薬株式会社 原発性腋窩多汗症の治療方法、及びその医薬

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US242A (en) 1837-06-22 moseley
US5292530A (en) 1991-06-02 1994-03-08 Helene Curtis, Inc. Stable anhydrous topically-active composition and suspending agent therefor
US5232689A (en) 1990-12-21 1993-08-03 Dow Corning Corporation Translucent antiperspirant compositions
GB2280111B (en) * 1993-07-16 1997-05-07 Union Camp Corp Clear gel antiperpirant compositions
US5895644A (en) 1997-11-20 1999-04-20 Colgate-Palmolive Company Clear antiperspirant stick with dibenzylidene sorbitol and guar and process of making same
US6433003B1 (en) 1999-04-23 2002-08-13 Arthur M. Bobrove Method for treating hyperhidrosis in mammals
ATE281847T1 (de) * 1999-12-13 2004-11-15 Symrise Gmbh & Co Kg Geruchsneutralisierungsmittel
US6319491B1 (en) * 2000-04-11 2001-11-20 Michael B. Whipple Anti-sweat lotion
US20030064040A1 (en) 2001-09-26 2003-04-03 Lukacsko Alison B. Compositions and methods for inhibiting eccrine perspiration in humans
JP2003113392A (ja) 2001-10-04 2003-04-18 Kiyomitsu Kawasaki 芳香・消臭組成物および該芳香・消臭組成物を含有する人体用芳香・消臭剤
US8252316B2 (en) 2002-05-03 2012-08-28 Purepharm Inc. Method of topically applying glycopyrrolate solution using absorbent pad to reduce sweating
BR0308051A (pt) 2003-12-15 2005-09-06 Natura Cosmeticos Sa Composição base para preparação de formulações multifuncionais para o cuidado e proteção da pele e cabelo
US20060088496A1 (en) 2004-10-25 2006-04-27 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Personal care compositions with salts of hydroxypropyl trialkylammonium substituted mono-saccharide
US7087560B2 (en) 2004-10-25 2006-08-08 Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. Personal care composition with salts of dihydroxypropyltri(C1-C3 alkyl) ammonium monosubstituted polyols
GB0428418D0 (en) 2004-12-24 2005-02-02 Novartis Ag Organic compounds
GB0428416D0 (en) 2004-12-24 2005-02-02 Novartis Ag Organic compounds
US8343467B2 (en) 2004-12-27 2013-01-01 Beiersdorf Ag Glycopyrrolate in cosmetic preparations
JP2007058971A (ja) 2005-08-24 2007-03-08 Alpine Electronics Inc 情報再生装置
CA2627982C (en) 2005-11-10 2013-09-10 Nicholas S. Bodor Soft anticholinergic esters
ATE529400T1 (de) 2005-11-10 2011-11-15 Nicholas S Bodor Weiche anticholinerge zwitterionen
US8071693B2 (en) 2006-06-22 2011-12-06 Sabic Innovative Plastics Ip B.V. Polysiloxane/polyimide copolymers and blends thereof
JP5371235B2 (ja) 2006-12-06 2013-12-18 ロート製薬株式会社 皮膚外用剤
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
US8618160B2 (en) 2007-10-18 2013-12-31 Rose U Topical glycopyrrolate formulations
AU2014227923B2 (en) * 2013-03-15 2019-02-14 Bodor Laboratories, Inc. Method of dosing and use of soft anticholinergic esters
US20150037269A1 (en) 2013-07-30 2015-02-05 Glaxosmithkline Intellectual Property Development Limited Topical compositions for treatment of excessive sweating and methods of use thereof
WO2015138700A1 (en) * 2014-03-13 2015-09-17 Bodor Laboratories, Inc. Use of selected anticholinergic zwitterions
US20150259283A1 (en) 2014-03-13 2015-09-17 Brickell Biotech, Inc. Formulation for soft anticholinergic analogs
US20180228770A1 (en) * 2015-07-21 2018-08-16 Bodor Laboratories, Inc. Formulation for soft anticholinergic analogs
TWI719046B (zh) * 2016-07-21 2021-02-21 美商波德實驗股份有限公司 軟性抗膽鹼類似物之製劑

Also Published As

Publication number Publication date
TWI719046B (zh) 2021-02-21
EP4218725A1 (en) 2023-08-02
TW202131913A (zh) 2021-09-01
AU2017298469B2 (en) 2023-02-02
WO2018017852A1 (en) 2018-01-25
BR112019001081A2 (pt) 2019-04-30
IL264311A (en) 2019-02-28
AU2023202689B2 (en) 2024-08-01
AU2023202689A1 (en) 2023-05-18
IL264311B (en) 2022-08-01
AU2017298469A1 (en) 2019-02-21
CA3031361A1 (en) 2018-01-25
TWI767507B (zh) 2022-06-11
ES2954308T3 (es) 2023-11-21
EP3487475B1 (en) 2023-06-07
US20200101044A1 (en) 2020-04-02
HUE062905T2 (hu) 2023-12-28
EP3487475A4 (en) 2020-03-04
PL3487475T3 (pl) 2023-10-30
US20210077459A1 (en) 2021-03-18
EP3487475A1 (en) 2019-05-29
CA3031361C (en) 2024-02-27
ZA201901060B (en) 2022-04-28
US11123325B2 (en) 2021-09-21
BR112019001081B1 (pt) 2022-06-14
US20180021300A1 (en) 2018-01-25
US20220000839A1 (en) 2022-01-06
PT3487475T (pt) 2023-09-05
IL295009A (en) 2022-09-01
PH12019500142A1 (en) 2019-07-29
FI3487475T3 (fi) 2023-08-25
US11052067B2 (en) 2021-07-06
US20190247362A1 (en) 2019-08-15
DK3487475T3 (da) 2023-09-11
US10959983B2 (en) 2021-03-30
TW201803561A (zh) 2018-02-01
MX2022009375A (es) 2022-09-02

Similar Documents

Publication Publication Date Title
PH12016501732A1 (en) Formulation for soft anticholinergic analogs
PH12018500184A1 (en) Formulation for soft anticholinergic analogs
PH12019500142A1 (en) Formulation for soft anticholinergic analogs
MX2018009824A (es) Composiciones para el cuidado personal.
MX2017013983A (es) Uso de agentes activos durante tratamientos quimicos.
BR122021018243A8 (pt) Composição tópica de baixo ph e método para aumentar a aplicação tópica de um ingrediente ativo cosmeticamente aceitável
WO2014188276A3 (en) Antioxidant compositions and methods of using the same
MX2022014634A (es) Metodos para la administracion linfatica de agentes activos.
NZ702087A (en) Pharmaceutical compositions and treatment of mastitis
PH12016500140A1 (en) Heterobicycloaryl rorc2 inhibitors and methods of use thereof
MX2017015012A (es) Formulaciones tópicas y orales que comprenden taurina y magnesio para la prevención y el tratamiento del acné.
MX2023002113A (es) Composicion que contiene dioxido de cloro y metodos para su uso.
PH12016500096A1 (en) Topical compositions for treatment of excessive sweating and methods of use thereof
ZA201801685B (en) Methods and compositions for soft anticholinergic esters
GB2564990A8 (en) Topical compositions for neuropathic pain
PH12019502145A1 (en) Agent for preventing myopia, treating myopia, and/or preventing myopia progression comprising tiotropium as active ingredient
MX2018002176A (es) Composiciones para aplicaciones topicas que comprenden peroxido de benzoilo y adapaleno.
MX2020012805A (es) Compuestos para el tratamiento del dolor, composiciones que comprenden los mismos, y metodos para utilizar los mismos.
WO2015044317A3 (en) Staphylococcus haemolyticus inhibitors for preventing and/or treating atopic dermatitis
MX2019011951A (es) Secretoma bacteriano para usarse en el tratamiento contra lesiones cutaneas.
MX2019000006A (es) Composiciones para el tratamiento de estrias y ulceras de origen isquemico.
NZ734845A (en) Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease
WO2019025803A3 (en) ANTIMICROBIAL COMPOSITION
TN2017000517A1 (en) MULTl-PEPTIDE COMPOSITION
FR3008315B1 (fr) Composition topique cosmetique protectrice vis-a-vis des xenobiotiques